NCOA5 and metastatic malignant neoplasm in the lymph nodes: There was a significant difference in the expression of NCOA5 in FIGO stage of ovarian cancer patients (P<0.001), but there were no significant differences with age, Differentiation degree and lymph node metastasis(P>0.05, Table 2).